Literature DB >> 16951684

Cholesterol glucosylation promotes immune evasion by Helicobacter pylori.

Christian Wunder1, Yuri Churin, Florian Winau, Dirk Warnecke, Michael Vieth, Buko Lindner, Ulrich Zähringer, Hans-Joachim Mollenkopf, Ernst Heinz, Thomas F Meyer.   

Abstract

Helicobacter pylori infection causes gastric pathology such as ulcer and carcinoma. Because H. pylori is auxotrophic for cholesterol, we have explored the assimilation of cholesterol by H. pylori in infection. Here we show that H. pylori follows a cholesterol gradient and extracts the lipid from plasma membranes of epithelial cells for subsequent glucosylation. Excessive cholesterol promotes phagocytosis of H. pylori by antigen-presenting cells, such as macrophages and dendritic cells, and enhances antigen-specific T cell responses. A cholesterol-rich diet during bacterial challenge leads to T cell-dependent reduction of the H. pylori burden in the stomach. Intrinsic alpha-glucosylation of cholesterol abrogates phagocytosis of H. pylori and subsequent T cell activation. We identify the gene hp0421 as encoding the enzyme cholesterol-alpha-glucosyltransferase responsible for cholesterol glucosylation. Generation of knockout mutants lacking hp0421 corroborates the importance of cholesteryl glucosides for escaping phagocytosis, T cell activation and bacterial clearance in vivo. Thus, we propose a mechanism regulating the host-pathogen interaction whereby glucosylation of a lipid tips the scales towards immune evasion or response.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16951684     DOI: 10.1038/nm1480

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  112 in total

Review 1.  Motility and chemotaxis in Campylobacter and Helicobacter .

Authors:  Paphavee Lertsethtakarn; Karen M Ottemann; David R Hendrixson
Journal:  Annu Rev Microbiol       Date:  2011       Impact factor: 15.500

2.  Phosphatidylethanolamine of Helicobacter pylori functions as a steroid-binding lipid in the assimilation of free cholesterol and 3β-hydroxl steroids into the bacterial cell membrane.

Authors:  Hirofumi Shimomura; Kouichi Hosoda; Shunji Hayashi; Kenji Yokota; Yoshikazu Hirai
Journal:  J Bacteriol       Date:  2012-03-09       Impact factor: 3.490

3.  Membrane-associated activation of cholesterol α-glucosyltransferase, an enzyme responsible for biosynthesis of cholesteryl-α-D-glucopyranoside in Helicobacter pylori critical for its survival.

Authors:  Hitomi Hoshino; Akiko Tsuchida; Kiyokazu Kametani; Masako Mori; Tomoko Nishizawa; Takefumi Suzuki; Hitomi Nakamura; Heeseob Lee; Yuki Ito; Motohiro Kobayashi; Junya Masumoto; Masaya Fujita; Minoru Fukuda; Jun Nakayama
Journal:  J Histochem Cytochem       Date:  2011-01       Impact factor: 2.479

4.  Role of the HefC efflux pump in Helicobacter pylori cholesterol-dependent resistance to ceragenins and bile salts.

Authors:  Elizabeth A Trainor; Katherine E Horton; Paul B Savage; Traci L Testerman; David J McGee
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

5.  Does Helicobacter pylori protect against asthma and allergy?

Authors:  Martin J Blaser; Yu Chen; Joan Reibman
Journal:  Gut       Date:  2008-01-14       Impact factor: 23.059

6.  Designing therapies against experimental visceral leishmaniasis by modulating the membrane fluidity of antigen-presenting cells.

Authors:  Subha Banerjee; June Ghosh; Subha Sen; Rajan Guha; Ranjan Dhar; Moumita Ghosh; Sanchita Datta; Bikramjit Raychaudhury; Kshudiram Naskar; Arun Kumar Haldar; C S Lal; K Pandey; V N R Das; Pradeep Das; Syamal Roy
Journal:  Infect Immun       Date:  2009-03-16       Impact factor: 3.441

Review 7.  Bacterial-mucosal interactions in inflammatory bowel disease: an alliance gone bad.

Authors:  Maciej Chichlowski; Laura P Hale
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-10-16       Impact factor: 4.052

Review 8.  H. pylori infection, inflammation and gastric cancer.

Authors:  Qurteeba Qadri; Roohi Rasool; G M Gulzar; Sameer Naqash; Zafar A Shah
Journal:  J Gastrointest Cancer       Date:  2014-06

9.  Alpha1,4GlcNAc-capped mucin-type O-glycan inhibits cholesterol alpha-glucosyltransferase from Helicobacter pylori and suppresses H. pylori growth.

Authors:  Heeseob Lee; Ping Wang; Hitomi Hoshino; Yuki Ito; Motohiro Kobayashi; Jun Nakayama; Peter H Seeberger; Minoru Fukuda
Journal:  Glycobiology       Date:  2008-05-05       Impact factor: 4.313

Review 10.  Carbohydrate-dependent defense mechanisms against Helicobacter pylori infection.

Authors:  Motohiro Kobayashi; Heeseob Lee; Jun Nakayama; Minoru Fukuda
Journal:  Curr Drug Metab       Date:  2009-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.